Femasys (FEMY) EBITDA (2020 - 2025)

Femasys (FEMY) has 6 years of EBITDA data on file, last reported at -$3.9 million in Q2 2025.

• For the quarter ending Q2 2025, EBITDA rose 14.07% year-over-year to -$3.9 million; the trailing twelve-month figure through Jun 2025 stood at -$19.2 million (down 16.25% YoY), and the FY2025 full-year result was -$17.6 million, up 1.11% from the prior year.
• EBITDA for Q2 2025 stood at -$3.9 million, up from -$5.5 million in the prior quarter.
• Across five years, EBITDA topped out at -$1.1 million in Q2 2021 and bottomed at -$5.5 million in Q1 2025.
• The 5-year median for EBITDA is -$3.0 million (2022), against an average of -$3.4 million.
• The widest annual swing landed in 2021, when EBITDA advanced 27.09%; it then tumbled 145.6% in 2022.
• A 5-year view of EBITDA shows it stood at -$2.4 million in 2021, then fell by 26.87% to -$3.0 million in 2022, then tumbled by 48.3% to -$4.4 million in 2023, then fell by 6.14% to -$4.7 million in 2024, then rose by 18.44% to -$3.9 million in 2025.
• The last three EBITDA figures came in at -$3.9 million (Q2 2025), -$5.5 million (Q1 2025), and -$4.7 million (Q4 2024), per Business Quant data.

Peer Comparison